SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1-Reference-Cited by-同舟云学术

SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1

Published:2016-09-08 Issue:46 Volume:7 Page:75023-75037
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Yoshioka Yuichiro¹²,Suzuki Takehiro³,Matsuo Yo⁴,Nakakido Makoto¹,Tsurita Giichiro⁵,Simone Cristiano⁶,Watanabe Toshiaki²,Dohmae Naoshi³,Nakamura Yusuke¹,Hamamoto Ryuji¹

Affiliation:

1. Section of Hematology/Oncology, Department of Medicine, The University of Chicago, MC2115 Chicago, IL 60637, USA

2. Department of Surgical Oncology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-8654, Japan

3. Biomolecular Characterization Unit, RIKEN Center for Sustainable Resource Science, Wako, Saitama 351-0198, Japan

4. OncoTherapy Science, Inc., Takatsu-ku, Kawasaki, Kanagawa 213-0012, Japan

5. Department of Surgery, IMSUT Hospital, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo 108-8639, Japan

6. Division of Medical Genetics, Department of Biomedical Science and Human Oncology (DIMO), University of Bari ‘Aldo Moro’, Bari 70124, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting non-histone methylation in gastrointestinal cancers: From biology to clinic;European Journal of Medicinal Chemistry;2024-11

2. Smyd3 negatively regulates the anti-viral pathway by promoting TAK1 degradation in teleost fish;Journal of Virology;2023-11-30

3. SMYD3 drives the proliferation in gastric cancer cells via reducing EMP1 expression in an H4K20me3-dependent manner;Cell Death & Disease;2023-06-29

4. The chromatin remodeling factors EP300 and TRRAP are novel SMYD3 interactors involved in the emerging ‘nonmutational epigenetic reprogramming’ cancer hallmark;Computational and Structural Biotechnology Journal;2023

5. Discovery of the 4-aminopiperidine-based compound EM127 for the site-specific covalent inhibition of SMYD3;European Journal of Medicinal Chemistry;2022-12